Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
Recruiting · NCT05366218 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 1 / Phase 2 | 2026-02-05 | NCT05366218 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital Tuebingen | 123 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Klinik für Kinder- und Jugendmedizin | Ulm | Germany | 1 |
| Klinikum Dr. von Haunersches Kinderspital | München | Germany | 1 |
| University childrens Hospital | Tübingen | Germany | 1 |
| Universitäts-Kinderklinik | Würzburg | Germany | 1 |
| Universitätsklinikum | Essen | Germany | 2 |
| Universitätsklinikum Düsseldorf | Düsseldorf | Germany | 11 |
| Universitätsklinikum Freiburg | Freiburg im Breisgau | Germany | 18 |
| Universitätsklinikum Schleswig-Holstein, Campus Kiel | Kiel | Germany | 9 |
| Universitätsklinikum, Klinik für Kinder- und Jugendmedizin | Frankfurt | Germany | 1 |
| Universitätsmedizin Berlin, Campus Virchow Klinikum | Berlin | Germany | 1 |
| Zentrum für Geburtshilfe, Kinder- und Jugendmedizin | Hamburg | Germany | 1 |